Name of undertaking |
Nature of business |
Country of incorporation |
% ownership |
AIFM to the Company and Irish co-investment limited |
England and Wales |
100% |
|
Esprit Capital Partners LLP^ |
partnership |
||
Elderstreet Holdings Limited^ |
Intermediate holding company |
England and Wales |
100% |
Elderstreet Investments Limited^ |
AIFM to Molten Ventures VCT plc and Molten SP I LLP |
England and Wales |
100% |
Grow Trustees Limited^ |
Trustee of the Group’s employment benefit trust |
England and Wales |
100% |
Molten Ventures Advisors Limited^ |
Dormant |
England and Wales |
100% |
Molten Ventures (Nominee) Limited^ |
Dormant |
England and Wales |
100% |
Encore Ventures LLP^ |
AIFM to the Encore Funds |
England and Wales |
100% |
Esprit Capital I (GP) Limited^¹ |
General Partner and co-invest vehicle |
England and Wales |
100% |
Esprit Capital I General Partner^¹ |
General Partner |
England and Wales |
100% |
Esprit Capital III Founder GP Limited* |
General Partner |
Scotland |
100% |
Esprit Capital III GP LP* |
General Partner |
Scotland |
100% |
Encore I Founder GP Limited † ¹ |
General Partner |
Cayman Islands |
100% |
Encore I GP Limited † ¹ |
Intermediate holding company |
Cayman Islands |
100% |
Esprit Capital Holdings Limited^ |
Dormant |
England and Wales |
100% |
Esprit Nominees Limited^ |
Nominee company |
England and Wales |
100% |
Esprit Capital I (CIP) Limited^¹ |
Dormant |
England and Wales |
100% |
Esprit Capital III MLP LLP^ |
Intermediate holding company |
England and Wales |
100% |
Esprit Capital III GP Limited^¹ |
General Partner (dormant) |
England and Wales |
100% |
Molten East Fund I GP S.a.r.l (formally |
|||
Molten Ventures Growth Fund I GP S.a.r.l) |
General Partner (dormant) |
Luxembourg |
100% |
Molten East SP GP LLP (formally |
|||
Molten Ventures Growth SP GP LLP) |
General Partner (dormant) |
England and Wales |
100% |
Molten Ventures FoF I GP LLP^ |
General Partner |
England and Wales |
100% |
Molten Ventures Investments GP LLP^ |
General Partner |
England and Wales |
100% |
Molten Ventures Ireland (GP) LLP^ |
General Partner |
England and Wales |
100% |
Forward Partners Group Limited^ |
Intermediate holding company |
England and Wales |
100% |
Forward Partners Management Company |
Intermediate holding company |
England and Wales |
100% |
| Limited^ |
|||
Forward Partners Venture Advance Ltd^ |
Revenue-based financing |
England and Wales |
100% |
Forward Partners General Partner Limited^ |
General Partner |
England and Wales |
100% |
Forward Partners Carried Interest General |
General Partner |
Scotland |
100% |
| Partner Limited* |
|||
FPGP Nominees Limited^ |
Dormant |
England and Wales |
100% |
Name of undertaking |
Principal activity |
Country of incorporation |
% ownership |
Molten Ventures (Ireland) Limited 1 |
Investment entity |
Republic of Ireland |
100% |
| Esprit Capital III, L.P. 2 |
Limited partnership pursuant to which the Group makes |
England and Wales |
100% |
certain investments |
|||
| Esprit Capital III B, L.P. 2 |
Limited partnership pursuant to which the Group makes |
England and Wales |
100% |
certain investments |
|||
| Esprit Capital IV LP 2 |
Limited partnership pursuant to which the Group makes |
England and Wales |
100% |
| certain investments |
|||
| Esprit Investments (1) L.P. 2 |
Limited partnership pursuant to which the Group makes |
England and Wales |
100% |
| certain investments |
|||
| Esprit Investments (2) LP 2 |
Limited partnership pursuant to which the Group makes |
England and Wales |
100% |
| certain investments |
|||
| Esprit Investments (1)(B) LP 2 |
Limited partnership pursuant to which the Group |
||
and Molten Ventures FoF I LP hold Fund of Fund |
England and Wales |
100% |
|
investments |
|||
| Esprit Investments (2)(B) LP 2 |
Limited partnership pursuant to which the Group |
||
and Molten Ventures FoF I LP hold Fund of Fund |
England and Wales |
100% |
|
investments |
|||
| SC_4_OF1 LP 4 |
Limited partnership pursuant to which the Group holds |
England and Wales |
100% |
| certain investments |
|||
| Molten Ventures Investments LP 2 |
Limited partnership pursuant to which the Group makes |
England and Wales |
100% |
certain investments |
|||
| Molten East Fund I SCSp 5 |
Limited partnership pursuant to which the Group makes |
Luxembourg |
100% |
certain investments (dormant) |
|||
| Molten Ventures Holdings Ltd 2 |
Intermediate Company and Qualifying Asset Holding |
England and Wales |
100% |
Company (“QAHC”) |
|||
| Esprit Investments (1)(B)(SC) LP 2 |
Limited partnership uses to hold the Group’s |
||
investments which were previously held by Seedcamp |
England and Wales |
100% |
|
Fund’s I and II |
|||
| Esprit Investments (2)(B)(II) LP 2 |
Limited partnership pursuant to which the Group makes |
England and Wales |
100% |
certain investments |
|||
| Molten Ventures FoF I LP 2 |
Limited partnership under the Group’s management |
England and Wales |
100% |
which makes Fund of Fund investments |
|||
| Molten Ventures FoF II LP 2 |
Limited partnership under the Group’s management |
England and Wales |
100% |
which makes Fund of Fund investments |
|||
| Molten Venture Investments (Ireland) I LP |
Limited Partnership under the Group’s management |
England and Wales |
56% |
which makes Irish domiciled investments |
|||
| Forward Partners 1 L.P. 2 |
Limited partnership pursuant to which the Group makes |
England and Wales |
100% |
certain investments |
|||
| Forward Partners II L.P. 2 |
Limited partnership pursuant to which the Group makes |
England and Wales |
100% |
certain investments |
|||
| Forward Partners III L.P. 2 |
Limited partnership pursuant to which the Group makes |
England and Wales |
100% |
certain investments |
|||
| Connect Ventures One LP 6 |
Limited partnership pursuant to which the Group holds |
England and Wales |
96% |
certain investments |
Name of undertaking |
Principal activity |
Country of incorporation |
Esprit Capital III Founder LP* |
Co-investment limited partnership/carry partner |
Scotland |
Esprit Investments (2) (Carried Interest) LP* |
Carry vehicle |
Scotland |
Esprit Capital III (Carried Interest) LP* |
Carry vehicle |
Scotland |
Esprit Investments (1) (Carried Interest) LP* |
Carry vehicle |
Scotland |
Molten East I Special Partner LP |
Carry vehicle |
Scotland |
Molten Ventures Investments (Carried Interest) LP* |
Carry vehicle |
Scotland |
Molten Ventures FoF I (Special Partner) LP* |
Carry vehicle |
Scotland |
Third Party Capital Investment vehicle structured as a |
||
Molten SP I LLP † |
limited liability partnership |
England and Wales |
Forward Partners Carried Interest L.P.* |
Carry vehicle |
Scotland |
Year ended |
Year ended |
|
31 March 2026 |
31 March 2025 |
|
£m |
£m |
|
Movement in unrealised gains/(losses) on investments held at fair value through profit or loss |
45.9 |
(15.7) |
Movement in realised gains on investments held at fair value through profit or loss |
79.5 |
60.0 |
Net foreign exchange gains/(losses) on investments held at fair value through profit or loss |
16.2 |
(21.6) |
Total movements on investments held at fair value through profit or loss |
141.6 |
22.7 |
Year ended |
Year ended |
|
31 March 2026 |
31 March 2025 |
|
£m |
£m |
|
Management fees |
15.9 |
18.1 |
Performance fees |
1.2 |
1.7 |
Promoter’s fees |
0.5 |
0.3 |
Directors’ and other fees |
0.1 |
0.8 |
Total fee income |
17.7 |
20.9 |
Year ended |
Year ended |
|
31 March 2026 |
31 March 2025 |
|
£m |
£m |
|
Employee and employee related expenses (Note 9) |
16.6 |
19.0 |
Legal and professional |
3.0 |
4.1 |
Performance fees payable |
1.1 |
1.3 |
Operational and support costs |
2.6 |
3.0 |
Other administrative costs |
1.2 |
1.0 |
Total administrative expenses |
24.5 |
28.4 |
Year ended |
Year ended |
|
31 March 2026 |
31 March 2025 |
|
£m |
£m |
|
Wages and salaries |
12.2 |
15.2 |
Pension costs – defined contribution plans |
1.2 |
1.2 |
Benefits (healthcare and life assurance) |
0.6 |
0.4 |
Recruitment costs |
0.4 |
0.1 |
Social security costs |
2.2 |
2.1 |
General employee and employee-related expenses |
16.6 |
19.0 |
Share-based payments – resulting from Company share option scheme |
2.6 |
4.9 |
Total employee benefit expenses |
19.2 |
23.9 |
Year ended |
Year ended |
|
31 March 2026 |
31 March 2025 |
|
Number |
Number |
|
Executive Directors |
3 |
3 |
Non-Executive Directors |
5 |
5 |
Investment |
20 |
22 |
Infrastructure |
30 |
32 |
Total |
58 |
62 |
Year ended |
Year ended |
|
31 March 2026 |
31 March 2025 |
|
£m |
£m |
|
Fees paid to the Company’s auditor for the audit of the Company and Group consolidated financial statements |
0.6 |
0.5 |
Fees payable to the Company’s auditors and associates for other services: |
||
Audit of the financial statements of the subsidiaries and related undertakings |
0.2 |
0.3 |
Audit-related assurance services |
0.1 |
0.1 |
Total fees payable to the Company’s auditors |
0.9 |
0.9 |
Year ended |
Year ended |
|
31 March 2026 |
31 March 2025 |
|
£m |
£m |
|
Interest and expenses on loans and borrowings |
(12.1) |
(12.6) |
Interest on leases (Note 23(ii)) |
(0.1) |
(0.1) |
Net foreign exchange loss |
– |
– |
Finance expense |
(12.2) |
(12.7) |
Interest income on cash and cash equivalents |
2.1 |
2.7 |
Net foreign exchange gain |
– |
0.2 |
Finance income |
2.1 |
2.9 |
Net finance expense |
(10.1) |
(9.8) |
Year ended |
Year ended |
|
31 March 2026 |
31 March2025 |
|
£m |
£m |
|
Current tax expense |
||
Current tax on profits for the year |
(1.0) |
– |
Total current tax expense |
(1.0) |
– |
Deferred tax (expense)/benefit |
||
Movement on deferred tax (note 24) |
(0.3) |
(1.0) |
Total deferred tax expense |
(0.3) |
(1.0) |
Income tax expense |
(1.3) |
(1.0) |
Year ended |
Year ended |
|
31 March 2026 |
31 March 2025 |
|
£m |
£m |
|
Profit for the year before tax |
121.6 |
0.2 |
Tax at the UK tax rate of 25% (31 March 2025: 25%) |
30.4 |
0.1 |
Gains on investments |
(35.4) |
(5.7) |
Movement on deferred tax (note 24) |
(0.3) |
(1.0) |
Other |
4.0 |
5.6 |
Income tax expense |
(1.3) |
(1.0) |
Profit/(Loss) |
|||
after tax |
No. of shares |
Pence |
|
£m |
m |
per share |
|
For the year ended 31 March 2026 |
120.3 |
174.1 |
69.1 |
For the year ended 31 March 2025 |
(0.8) |
184.2 |
(0.4) |
Profit/(Loss) |
|||
after tax |
No. of shares 1 |
Pence |
|
£m |
m |
per share |
|
For the year ended 31 March 2026 |
120.3 |
175.3 |
68.6 |
For the year ended 31 March 2025 |
(0.8) |
184.8 |
(0.4) |
Net assets |
No. of shares |
Pence |
|
£m |
m |
per share |
|
As at 31 March 2026 |
1,323.8 |
174.1 |
760.0 |
As at 31 March 2025 |
1,235.8 |
184.2 |
671.0 |
Net assets |
No. of shares 1 |
Pence |
|
£m |
m |
per share |
|
As at 31 March 2026 |
1,323.8 |
175.3 |
755.0 |
As at 31 March 2025 |
1,235.8 |
184.8 |
669.0 |
Fair |
|||||||||
value per |
|||||||||
b/f |
Granted in |
Lapsed in |
Exercised |
c/f |
Exercise |
granted |
|||
Date of |
1 April 2025 |
the year |
the year |
in the year |
31 Mar 2026 |
Vesting |
price |
instrument |
|
Grant |
(No.) |
(No.) |
(No.) |
(No.) |
(No.) |
period |
(pence) |
(pence) |
|
28–Nov–16 |
499,320 |
– |
– |
(326,385) |
172,935 |
3 years |
355 |
64.1 |
|
Molten Ventures |
11–Nov–17 |
120,000 |
– |
– |
– |
120,000 |
3 years |
530 |
89.3 |
plc 2016 Company |
28–Nov–17 |
306,384 |
– |
– |
(41,549) |
264,835 |
3 years |
387 |
70.9 |
Share Option Scheme |
30–Jul–18 |
650,750 |
– |
(109,600) |
– |
541,150 |
3 years |
530 |
67.8 |
(“CSOP”) |
12–Feb–19 |
546,868 |
– |
(80,000) |
– |
466,868 |
3 years |
449 |
81.2 |
26–Jul–21 |
28,754 |
– |
(1,522) |
(6,088) |
21,144 |
1 year |
1 |
986 |
|
29–Jun–20 |
123,774 |
– |
– |
(46,275) |
77,499 |
3 years |
1 |
449 |
|
29–Jun–20 |
131,359 |
– |
– |
(94,744) |
36,615 |
3 years |
1 |
81 |
|
16–Jul–21 |
118,187 |
– |
(544) |
(19,480) |
98,163 |
3 years |
1 |
940 |
|
17–Jun–22 |
373,006 |
– |
(373,006) |
– |
– |
3 years |
1 |
540 |
|
17–Jun–22 |
543,609 |
– |
(543,609) |
– |
– |
3 years* |
1 |
540 |
|
22–Jun–23 |
77,849 |
– |
(77,849) |
– |
– |
2 years |
1 |
241 |
|
Molten Ventures plc |
22–Jun–23 |
113,453 |
– |
(113,453) |
– |
– |
2 years |
1 |
447 |
Long-Term Incentive |
23–Jun–23 |
2,156,156 |
– |
(418,690) |
– |
1,737,466 |
3 years |
1 |
274 |
Plan (“LTIP”) |
19–Jun–24 |
803,099 |
– |
(234,383) |
– |
568,716 |
3 years |
1 |
359 |
28–Jun–24 |
768,153 |
– |
(130,389) |
– |
637,764 |
3 years |
1 |
365 |
|
01–Sep–24 |
51,582 |
– |
– |
– |
51,582 |
3 years |
1 |
409 |
|
03–Dec–24 |
30,669 |
– |
– |
– |
30,669 |
3 years |
1 |
271 |
|
20–Jun–25 |
– |
1,056,892 |
– |
– |
1,056,892 |
3 years |
1 |
197 |
|
20–Jun–25 |
– |
848,106 |
(162,299) |
– |
685,807 |
3 years |
1 |
292 |
|
20–Jun–25 |
– |
62,292 |
– |
– |
62,292 |
3 years |
1 |
291 |
|
17–Jun–22 |
211,110 |
– |
– |
(150,925) |
60,185 |
2 years |
1 |
540 |
|
| Molten Ventures plc |
22–Jun–23 |
44,058 |
– |
– |
(31,498) |
12,560 |
2 years |
1 |
241 |
Deferred Benefit Plan |
|||||||||
(“DBP”) |
19–Jun–24 |
174,070 |
– |
– |
– |
174,070 |
2 years |
1 |
401 |
20–Jun–25 |
– |
327,023 |
– |
– |
327,023 |
2 years |
1 |
292 |
|
Total |
7,872,210 |
2,294,313 |
(2,245,344) |
(716,944) |
7,204,235 |
Year ended |
Year ended |
|
31 March 2026 |
31 March 2025 |
|
As at 1 April |
7,872,210 |
6,983,618 |
Granted during the year |
2,294,313 |
1,994,088 |
Lapsed in the year |
(2,245,344) |
(1,079,400) |
Exercised during the year |
(716,944) |
(26,096) |
As at 31 March |
7,204,235 |
7,872,210 |
Customer |
|||
Goodwill |
contracts |
Total |
|
As at 31 March 2026 |
£m |
£m |
£m |
Cost |
|||
Cost carried forward as at 1 April 2025 |
10.4 |
1.1 |
11.5 |
Additions during the period |
– |
– |
– |
Cost as at 31 March 2026 |
10.4 |
1.1 |
11.5 |
Accumulated amortisation |
|||
Amortisation carried forward as at 1 April 2025 |
– |
(1.1) |
(1.1) |
Charge for the period |
– |
– |
– |
Accumulated amortisation as at 31 March 2026 |
– |
(1.1) |
(1.1) |
Net book value: |
|||
As at 31 March 2026 |
10.4 |
– |
10.4 |
Customer |
|||
Goodwill |
contracts |
Total |
|
As at 31 March 2025 |
£m |
£m |
£m |
Cost |
|||
Cost carried forward as at 1 April 2024 |
10.4 |
1.1 |
11.5 |
Additions during the period |
– |
– |
– |
Cost as at 31 March 2025 |
10.4 |
1.1 |
11.5 |
Accumulated amortisation |
|||
Amortisation carried forward as at 1 April 2024 |
– |
(1.0) |
(1.0) |
Charge for the period |
– |
(0.1) |
(0.1) |
Accumulated amortisation as at 31 March 2025 |
– |
(1.1) |
(1.1) |
Net book value: |
|||
As at 31 March 2025 |
10.4 |
– |
10.4 |
Year ended |
Year ended |
|
31 March 2026 |
31 March 2025 |
|
£m |
£m |
|
As at 1 April |
1,279.9 |
1,292.1 |
Investments made in the period1 |
89.5 |
72.6 |
Realisation of investments during the year |
(119.6) |
(134.6) |
Carry external |
7.8 |
12.4 |
Portfolio Deferred tax |
(1.4) |
– |
Non-investment cash movements |
14.1 |
14.7 |
Unrealised gains/(losses) on the revaluation of investments |
143.0 |
22.7 |
As at 31 March |
1,413.3 |
1,279.9 |
Interest FD category* |
||||
at reporting date/ |
||||
Name |
Address |
Principal activity |
Type of shareholding |
partnership interest |
Earlybird GmbH & Co. |
c/o Earlybird Venture Capital, |
Limited partnership pursuant to which |
Partnership interest |
E |
Beteiligungs-KG IV |
Promenadeplatz 9 80333 Munich |
the Group holds certain investments |
||
Earlybird Special |
c/o Earlybird Venture Capital, |
Limited partnership pursuant to which |
Partnership interest |
E |
Opportunities LP |
Promenadeplatz 9 80333 Munich |
the Group holds certain investments |
||
Earlybird DWES |
c/o Earlybird Venture Capital, |
Limited partnership pursuant to which |
||
Fund VI GmbH & |
Promenadeplatz 9 80333 Munich |
the Group holds certain investments |
Partnership interest |
E |
Co. KG |
||||
Recode Health |
95 3rd Street, 2nd Floor, |
Limited partnership pursuant to which |
||
Opportunities Fund I, |
San Francisco, CA 94103 |
the Group holds certain investments |
Partnership interest |
E |
LP |
||||
2480 Regents Court, The Crescent, |
||||
| Vektor UK Limited |
Birmingham Business Park, |
Limited partnership pursuant to which |
Partnership interest |
D |
West Midlands B37 7YE, |
the Group holds certain investments |
|||
United Kingdom |
||||
| Black Seed LP |
Coldharbour Lane Unit 63, |
Limited partnership pursuant to which |
Partnership interest |
D |
Brixton Village, London SW9 8PS |
the Group holds certain investments |
|||
| Realeyes OÜ |
86-90 Paul Street, London, |
Trading company |
Ordinary Shares |
E |
EC2A 4NE, United Kingdom |
Preference shares |
|||
| Makers Academy |
Unit 2f Zetland House, |
Ordinary Shares |
E |
|
| Limited |
5-25 Scrutton St, |
Trading company |
Preference shares |
|
London, England, EC2A 4HJ |
||||
| SettleMint NV |
Philipssite 5 bus 30, |
Trading company |
||
3001 Leuven, Belgium |
||||
Driftrock Limited |
124 City Road, London, |
Trading company |
Ordinary Shares |
E |
United Kingdom, EC1V 2NX |
Preference shares |
|||
RavenPack |
Centro Negocios Oasis, Local 8, |
Ordinary Shares |
||
International S.L.U. |
Ctra Nacional 340, KM 176, |
Trading company |
Preference shares |
D |
Marbella, Malaga 29602, Spain |
Ordinary Shares |
|||
| Outthink LTD |
80 Cheapside, London, |
Trading company |
Preference shares |
D |
| United Kingdom, EC2V 6EE |
||||
Ordinary Shares |
D |
|||
| 74 Fitzwilliam Lane, |
Preference shares |
|||
| &Open Incentive |
Dublin 2, D02 YX95, |
Trading company |
||
Limited |
Ireland |
Ordinary Shares |
D |
|
| Preference shares |
||||
Speedinvest I |
Praterstraße 1, Stiege 1, Top 6 |
|||
Continuation I GmbH |
1020 Vienna |
Limited partnership pursuant to which |
Partnership interest |
E |
& Co KG |
Austria |
the Group holds certain investments |
Right-of-use |
Furniture and |
Computer |
Leasehold |
||
assets |
fixtures |
equipment |
Improvements |
Total |
|
Year ended 31 March 2026 |
£m |
£m |
£m |
£m |
£m |
Cost |
|||||
Cost carried forward as at 1 April 2025 |
2.0 |
0.8 |
0.2 |
– |
3.0 |
Additions during the year |
– |
– |
0.1 |
0.1 |
0.2 |
Disposals during the year |
– |
– |
– |
– |
– |
Cost as at 31 March 2026 |
2.0 |
0.8 |
0.3 |
0.1 |
3.2 |
Accumulated depreciation |
|||||
Depreciation carried forward as at 1 April 2025 |
(0.3) |
(0.7) |
(0.2) |
– |
(1.2) |
Charge for the year |
(0.4) |
(0.1) |
– |
– |
(0.5) |
Disposals during the year |
– |
– |
– |
– |
– |
Accumulated depreciation as at 31 March 2026 |
(0.7) |
(0.8) |
(0.2) |
– |
(1.7) |
Net book value: |
|||||
As at 31 March 2026 |
1.3 |
– |
0.1 |
0.1 |
1.5 |
Right-of-use |
Furniture and |
Computer |
Leasehold |
||
assets |
fixtures |
equipment |
Improvements |
Total |
|
Year ended 31 March 2025 |
£m |
£m |
£m |
£m |
£m |
Cost |
|||||
Cost carried forward as at 1 April 2024 |
1.6 |
0.8 |
0.2 |
– |
2.6 |
Additions during the year |
2.0 |
– |
– |
– |
2.0 |
Disposals during the year |
(1.6) |
– |
– |
– |
(1.6) |
Cost as at 31 March 2025 |
2.0 |
0.8 |
0.2 |
– |
3.0 |
Accumulated depreciation |
|||||
Depreciation carried forward as at 1 April 2024 |
(1.6) |
(0.7) |
(0.2) |
– |
(2.5) |
Charge for the year |
(0.3) |
– |
– |
– |
(0.3) |
Disposals during the year |
1.6 |
– |
– |
– |
1.6 |
Accumulated depreciation as at 31 March 2025 |
(0.3) |
(0.7) |
(0.2) |
– |
(1.2) |
Net book value: |
|||||
As at 31 March 2025 |
1.7 |
0.1 |
– |
– |
1.8 |
31 March 2026 |
31 March 2025 |
|
£m |
£m |
|
Cash at bank and on hand |
27.8 |
39.8 |
Cash equivalents |
23.9 |
49.2 |
Total |
51.7 |
89.0 |
31 March 2026 |
31 March 2025 |
|
£m |
£m |
|
Trade receivables |
2.5 |
0.6 |
Other receivables and prepayments |
1.6 |
1.3 |
Total |
4.1 |
1.9 |
31 March 2026 |
31 March 2025 |
|
£m |
£m |
|
Not past due |
2.5 |
0.5 |
Past due 1–30 days |
– |
– |
Past due 31–60 days |
– |
– |
More than 60 days |
– |
0.1 |
Total |
2.5 |
0.6 |
31 March 2026 |
31 March 2025 |
|
£m |
£m |
|
Trade payables |
(2.6) |
(0.9) |
Other taxation and social security |
(0.6) |
(0.3) |
Other payables |
(2.8) |
(3.4) |
Accruals and deferred income |
(7.2) |
(8.5) |
Total |
(13.2) |
(13.1) |
31 March 2026 |
31 March 2025 |
|
£m |
£m |
|
Current liabilities |
||
Leases |
(0.4) |
(0.3) |
Deferred consideration on investments |
(10.0) |
– |
Loans and borrowings |
– |
– |
Total current financial liabilities |
(10.4) |
(0.3) |
Non-current liabilities |
||
Leases |
(0.9) |
(1.3) |
Loans and borrowings |
(119.6) |
(119.7) |
Total non-current financial liabilities |
(120.5) |
(121.0) |
Total |
(130.9) |
(121.3) |
Borrowings |
Leases |
|
£m |
£m |
|
At 1 April 2024 |
(89.4) |
– |
Capitalisation of costs |
– |
(1.8) |
Amortisation of costs |
(0.3) |
(0.1) |
Drawdowns |
(30.0) |
– |
Payment of lease liabilities |
– |
0.3 |
At 31 March 2025 |
(119.7) |
(1.6) |
Amortisation of costs |
0.1 |
(0.1) |
Payment of lease liabilities |
– |
0.4 |
At 31 March 2026 |
(119.6) |
(1.3) |
31 March 2026 |
31 March 2025 |
|
£m |
£m |
|
Bank loan senior facility amount |
180.0 |
180.0 |
Interest rate |
SONIA + 5.5% |
SONIA + 5.5% |
Drawn at balance sheet date |
(120.0) |
(120.0) |
Arrangement fees |
0.4 |
0.3 |
Loan liability balance |
(119.6) |
(119.7) |
Undrawn facilities at balance sheet date |
60.0 |
60.0 |
31 March 2026 |
31 March 2025 |
|
£m |
£m |
|
Right-of-use asset |
1.3 |
1.7 |
Total |
1.3 |
1.7 |
31 March 2026 |
31 March 2025 |
|
£m |
£m |
|
Current |
(0.4) |
(0.3) |
Non-current |
(0.9) |
(1.3) |
Total |
(1.3) |
(1.6) |
31 March 2026 |
31 March 2025 |
|
£m |
£m |
|
Interest on lease liabilities |
(0.1) |
(0.1) |
Depreciation charge for the period on right-of-use assets |
(0.3) |
(0.3) |
31 March 2026 |
31 March 2025 |
|
£m |
£m |
|
Arising on share-based payments |
1.1 |
(1.2) |
Arising on the investment portfolio |
(14.1) |
(11.4) |
Other timing differences |
– |
(0.1) |
Deferred tax liability |
(13.0) |
(12.7) |
Year ended 31 March 2026 – Allotted and fully paid |
Number |
Pence |
£m |
As at 1 April |
189,046,450 |
1 |
1.9 |
As at 31 March |
189,046,450 |
1 |
1.9 |
Year ended 31 March 2025 – Allotted and fully paid |
Number |
Pence |
£m |
As at 1 April |
189,046,450 |
1 |
1.9 |
As at 31 March |
189,046,450 |
1 |
1.9 |
31 March 2026 |
31 March 2025 |
|
Allotted and fully paid |
£m |
£m |
As at 1 April |
671.2 |
671.2 |
Premium arising on the issue of ordinary shares |
– |
– |
Equity issuance costs |
– |
– |
As at 31 March |
671.2 |
671.2 |
31-Mar-26 |
31-Mar-25 |
|||
No. of shares |
No. of shares |
|||
m |
£m |
m |
£m |
|
As at 1 April |
(6.6) |
(27.8) |
(1.1) |
(8.8) |
Acquisition of shares by the Trust |
(0.2) |
(0.5) |
(0.6) |
(2.1) |
Acquisition of shares as part of the share buy back programme |
(10.0) |
(37.5) |
(4.9) |
(16.9) |
Disposal or transfer of shares by the Trust* |
0.7 |
3.1 |
– |
– |
As at 31 March |
(16.1) |
(62.7) |
(6.6) |
(27.8) |
Share-based |
||||
payments |
Share-based |
|||
reserve resulting |
payments |
|||
from Company |
reserve resulting |
|||
Merger relief |
share option |
from acquisition |
Total other |
|
reserve |
scheme |
of subsidiary |
reserves |
|
Year ending 31 March 2026 |
£m |
£m |
£m |
£m |
As at 1 April |
50.0 |
18.8 |
10.8 |
79.6 |
Share-based payments |
– |
2.6 |
– |
2.6 |
Share-based payments – exercised during the period |
– |
(1.7) |
– |
(1.7) |
Share-based payments – Lapsed & Expired |
– |
(3.2) |
– |
(3.2) |
As at 31 March |
50.0 |
16.5 |
10.8 |
77.3 |
Share-based |
||||
payments |
Share-based |
|||
reserve resulting |
payments |
|||
from Company |
reserve resulting |
|||
Merger relief |
share option |
from acquisition |
Total other |
|
reserve |
scheme |
of subsidiary |
reserves |
|
Year ending 31 March 2025 |
£m |
£m |
£m |
£m |
As at 1 April |
50.0 |
13.9 |
10.8 |
33.3 |
Share-based payments |
– |
4.9 |
– |
4.9 |
As at 31 March |
50.0 |
18.8 |
10.8 |
79.6 |
Year ended |
Year ended |
||
31 March 2026 |
31 March 2025 |
||
Notes |
£m |
£m |
|
Adjustments to reconcile operating profit/(loss) to net cash outflow in operating activities: |
|||
Revaluation of investments held at fair value through profit or loss |
6 |
(141.6) |
(22.7) |
Depreciation and amortisation |
15, 18 |
0.5 |
0.3 |
Share-based payments – resulting from Company share option scheme |
14 |
2.6 |
4.9 |
Finance income |
11 |
(2.1) |
(2.9) |
Finance expense |
11 |
12.2 |
12.7 |
Increase in deferred tax |
24 |
0.3 |
1.0 |
Increase in trade and other receivables and other working capital movements |
21 |
(2.2) |
(0.3) |
Increase in trade and other payables |
22 |
0.1 |
4.1 |
Adjustments to reconcile operating profit/(loss) to net cash outflow in operating activities |
(130.2) |
(2.9) |
Fair Value of |
Non- |
Fair Value |
Fair Value of |
|||||
Investments |
investment |
Movement |
movement |
Investments |
||||
31 March |
cash |
in Foreign |
Movement |
31 March |
31 March |
|||
2025 |
Investments |
Realisations |
movement |
Exchange |
in Fair Value |
2026 |
2026 |
|
Investments |
£m |
£m |
£m |
£m |
£m |
£m |
£m |
£m |
Gross Portfolio Value |
1,367.4 |
89.5 |
(119.6) |
– |
16.2 |
171.9 |
188.1 |
1,525.4 |
Carry External |
(87.5) |
– |
7.8 |
– |
– |
(31.0) |
(31.0) |
(110.7) |
Portfolio Deferred tax |
– |
– |
– |
– |
– |
(1.4) |
(1.4) |
(1.4) |
Trading carry & co-invest |
– |
– |
– |
– |
– |
– |
– |
– |
Non-investment cash movement |
– |
– |
– |
14.1 |
– |
(14.1) |
(14.1) |
– |
Net Portfolio Value |
1,279.9 |
89.5 |
(111.8) |
14.1 |
16.2 |
125.4 |
141.6 |
1,413.3 |
Fair Value of |
Non- |
Fair Value |
Fair Value of |
|||||
Investments |
investment |
Movement |
movement |
Investments |
||||
31 March |
cash |
in Foreign |
Movement |
31 March |
31 March |
|||
2024 |
Investments |
Realisations |
movement |
Exchange |
in Fair Value |
2025 |
2025 |
|
Investments |
£m |
£m |
£m |
£m |
£m |
£m |
£m |
£m |
Gross Portfolio Value |
1,378.9 |
72.6 |
(134.6) |
– |
(21.6) |
72.1 |
50.5 |
1,367.4 |
Carry external |
(87.1) |
– |
12.4 |
– |
– |
(12.8) |
(12.8) |
(87.5) |
Portfolio deferred tax |
– |
– |
– |
– |
– |
– |
– |
– |
Trading carry and co-invest |
0.3 |
– |
– |
– |
– |
(0.3) |
(0.3) |
– |
Non-investment cash movement |
– |
– |
– |
14.7 |
– |
(14.7) |
(14.7) |
– |
Net Portfolio Value |
1,292.1 |
72.6 |
(122.2) |
14.7 |
(21.6) |
44.3 |
22.7 |
1,279.9 |
Fair value measurements | Level 1 | Level 2 | Level 3 | Total |
At 31 March 2026 | £m | £m | £m | £m |
Financial assets at fair value through profit or loss | ||||
Quoted investments | – | – | – | – |
Unquoted investments being made up of: | ||||
Unquoted investments – enterprise technology | – | – | 592.3 | 592.3 |
Unquoted investments – consumer technology | – | – | 217.3 | 217.3 |
Unquoted investments – hardware and deeptech | – | – | 335.4 | 335.4 |
Unquoted investments – digital health | – | – | 47.9 | 47.9 |
Unquoted investments – other* | – | – | 332.5 | 332.5 |
Total financial assets | – | – | 1,525.4 | 1,525.4 |
Fair value measurements | Level 1 | Level 2 | Level 3 | Total |
At 31 March 2025 | £m | £m | £m | £m |
Financial assets at fair value through profit or loss | ||||
Quoted investments | – | – | – | – |
Unquoted investments being made up of: | ||||
Unquoted investments – enterprise technology | – | – | 540.0 | 540.0 |
Unquoted investments – consumer technology | – | – | 235.7 | 235.7 |
Unquoted investments – hardware and deeptech | – | – | 289.5 | 289.5 |
Unquoted investments – digital health | – | – | 34.1 | 34.1 |
Unquoted investments – other* | – | – | 268.1 | 268.1 |
Total financial assets | – | – | 1,367.4 | 1,367.4 |
Level 3 valuations | £m |
Opening balance at 1 April 2024 | 1,378.9 |
Investments | 72.6 |
Losses | 50.5 |
Realisations | (134.6) |
Unadjusted closing balance at 31 March 2025 | 1,367.4 |
Transfer to Level 1 | – |
Closing balance at 31 March 2025 | 1,367.4 |
Investments | 89.5 |
Gains | 188.1 |
Realisations | (119.6) |
Unadjusted closing balance at 31 March 2026 | 1,525.4 |
Transfer to Level 1 | – |
Closing balance at 31 March 2026 | 1,525.4 |
Fair value | Fair value | |||||
impact of | impact of | |||||
Valuation | Fair value at | Sensitivity on | sensitivities | sensitivities | ||
technique | Sector | Significant input* | 31-Mar-26 | significant input | (£m) +10% | (£m) -10% |
Calibrated | All | Calibrated round enterprise value – Pre and | 545.2 | 10% sensitivity applied | 497.4 | 586.8 |
price of | post year- end round enterprise values have | to the premium and | (FY25: 440.8) | (FY25: 550.4) | ||
recent | been calibrated with appropriate premiums | (FY25: 493.9) | discount to last round | 101.3 | 121.7 | |
investment | Enterprise | and discounts taken to reflect movements in | 113.2 | price | ||
tech | publicly listed peer multiples, future revenue | |||||
projections and timing risk. Premiums and | ||||||
discounts were applied to 56% (2025: 40%) | (FY25: 180.6) | (FY25: 166.8) | (FY25: 194.3) | |||
Consumer | of the fair value of investments measured at | 181.1 | 163.0 | 199.2 | ||
tech | calibrated price of recent investment. The | |||||
range of premiums applied is 4.0% - 94.6% | (FY25: 181.5) | (FY25: 158.1) | (FY25: 200.2) | |||
(2025: 0.3% to 1.9%). The range of discounts | 210.3 | 195.3 | 225.3 | |||
Hardware & | taken is 1.1% - 71.7% (2025: 0.2% - 89.6%). | |||||
Deeptech | The weighted average discount taken is | |||||
16.2% (2025: 15%). Less discounts have | (FY25: 126.6) | (FY25: 111.3) | (FY25: 150.3) | |||
been applied in the current year, reflecting | 40.6 | 37.8 | 40.6 | |||
Digital health | calibration to the market. | |||||
& wellness | (FY25: 5.2) | (FY25: 4.6) | (FY25: 5.6) | |||
Market | All | Revenue-multiples are applied to the | 647.7 | 10% sensitivity applied | 706.5 | 583.9 |
comparables | revenue of our portfolio companies to | (FY25: 605.8) | to the revenue–multiple | (FY25: 658.6) | (FY25: 542.7) | |
determine their enterprise value. | 10% sensitivity applied | 706.5 | 583.9 | |||
Implied revenue-multiple – the portfolio | to the revenue of the | |||||
we have is diversified across sectors and | portfolio company | (FY25: 658.6) | (FY25: 542.7) | |||
geographies and the companies which | ||||||
Enterprise | have valuations based on revenue- | 479.1 | 10% sensitivity applied | 522.1 | 433.3 | |
tech | multiples have a range of multiples of | (FY25: 359.7) | to the revenue–multiple | (FY25: 394.1) | (FY25: 325.0) | |
between 0.7x - 22.0x (2025: 0.9x–17.0x) and | ||||||
a weighted average multiple of 5.4x | 10% sensitivity applied | 522.1 | 433.3 | |||
(2025: 6.7x). | to the revenue of the | (FY25: 394.1) | (FY25: 325.0) | |||
Revenue – we select forward revenues | portfolio company | |||||
Consumer | from our portfolio companies mostly with | 36.2 | 10% sensitivity applied | 39.7 | 32.7 | |
tech | reference to financial updates in their | (FY25: 54.2) | to the revenue–multiple | (FY25: 58.0) | (FY25: 49.8) | |
board packs, adjusted where required in | ||||||
the event we do not have forward-looking | 10% sensitivity applied | 39.7 | 32.7 | |||
information. Our core portfolio makes up | to the revenue of the | (FY25: 58.0) | (FY25: 49.8) | |||
64% (2025: 61%) of the GPV and revenue | portfolio company | |||||
Hardware & | growth in the core portfolio for 2026 is | 125.1 | 10% sensitivity applied | 136.9 | 111.5 | |
Deeptech | 40% (2025: 36%). The multiple range has | (FY25: 163.0) | to the revenue–multiple | (FY25: 175.2) | (FY25: 141.9) | |
changed from the prior financial year to | ||||||
March 2026, now ranging between 0.7x | 10% sensitivity applied | 136.9 | 111.5 | |||
and 22.0x (FY25: 0.9x–17.0x). There has also | to the revenue of the | (FY25: 175.2) | (FY25: 141.9) | |||
been a decrease in the weighted average | portfolio company | |||||
Digital health | multiple to 5.4x (FY25: 6.7x), reflecting the | 7.3 | 10% sensitivity applied | 7.8 | 6.4 | |
& wellness | more significant weighting of larger assets. | (FY25: 28.9) | to the revenue–multiple | (FY25: 31.3) | (FY25: 26.0) | |
10% sensitivity applied | 7.8 | 6.4 | ||||
to the revenue of the | (FY25: 31.3) | (FY25: 26.0) | ||||
portfolio company | ||||||
NAV of | All | NAV of funds, adjusted where required | 332.5 | 10% sensitivity applied | 365.8 | 299.3 |
underlying | – net asset values of underlying funds | (FY25: 267.7) | to the adjusted NAV of | (FY25: 294.6) | (FY25: 241.0) | |
fund | Enterprise | reported by the manager. These are | funds | |||
tech | reviewed for compliance with our policies | – | – | – | ||
and are calibrated for any cash and known | (FY25: nil) | (FY25: nil) | (FY25: nil) | |||
Consumer | valuation movements where reporting | – | – | – | ||
tech | periods do not align. | (FY25: nil) | (FY25: nil) | (FY25: nil) | ||
Hardware & | – | – | – | |||
Deeptech | (FY25: nil) | (FY25: nil) | (FY25: nil) | |||
Digital health | – | – | – | |||
& wellness | (FY25: nil) | (FY25: nil) | (FY25: nil) | |||
Other | 332.5 | 365.8 | 299.3 | |||
(FY25: 267.7) | (FY25: 294.9) | (FY25: 241.3) |
31 March 2026 |
31 March 2025 |
|
Foreign currency exposures – Investments |
£m |
£m |
Investments – exposures in EUR |
655.7 |
614.1 |
10% decrease in GBP |
721.3 |
682.4 |
10% increase in GBP |
590.1 |
558.3 |
Investments – exposures in USD |
454.8 |
326.6 |
10% decrease in GBP |
500.3 |
362.8 |
10% increase in GBP |
409.3 |
296.9 |
31 March 2026 |
31 March 2025 |
|
Foreign currency exposures – Cash |
£m |
£m |
Cash denominated in EUR |
9.5 |
8.5 |
10% decrease in EUR: GBP |
8.5 |
7.7 |
10% increase in EUR: GBP |
10.4 |
9.4 |
Cash denominated in USD |
11.8 |
12.0 |
10% decrease in USD: GBP |
10.6 |
10.9 |
10% increase in USD: GBP |
13.0 |
13.3 |
31 March 2026 |
31 March 2025 |
|
Foreign currency exposures – Equity |
£m |
£m |
Shareholders’ Equity |
1,323.8 |
1,235.8 |
10% decrease in EUR: GBP/USD: GBP |
1,191.4 |
1,054.6 |
10% increase in EUR: GBP/USD: GBP |
1,456.2 |
1,289.0 |
| Valuation methodology |
||||||
| Calibrated price of |
||||||
Revenue–multiple £m |
NAV of underlying fund £m |
recent investment £m |
||||
-10% |
10% |
-10% |
10% |
-10% |
10% |
|
As at 31 March 2026 |
(76.6) |
51.7 |
(33.3) |
33.3 |
(55.8) |
44.2 |
As at 31 March 2025 |
(58.4) |
56.9 |
(26.8) |
26.8 |
(44.0) |
45.9 |
| Valuation methodology |
||||||
| Calibrated price of |
||||||
Revenue–multiple £m |
NAV of underlying fund £m |
recent investment £m |
||||
-20% |
20% |
-20% |
20% |
-20% |
20% |
|
As at 31 March 2026 |
(139.6) |
107.5 |
(66.5) |
66.5 |
(102.5) |
93.0 |
As at 31 March 2025 |
(117.9) |
111.0 |
(53.6) |
53.6 |
(89.0) |
91.7 |
Contractual maturities of liabilities |
Less than |
Between |
Between |
Total contractual |
Carrying |
|
at 31 March 2026 (£m) |
6 months |
6–12 months |
1–2 years |
2–5 years |
cash flows |
amount |
Trade and other payables |
(13.2) |
– |
– |
– |
(13.2) |
(13.2) |
Fees on facility |
0.2 |
– |
– |
– |
0.2 |
0.2 |
Facility |
(5.9) |
(5.9) |
(11.8) |
(95.9) |
(119.5) |
(120.0) |
Provisions |
– |
(0.1) |
– |
– |
(0.1) |
(0.1) |
Current lease liabilities |
(0.2) |
(0.2) |
– |
– |
(0.4) |
(0.4) |
Non-current lease liabilities |
– |
– |
(0.8) |
(0.1) |
(0.9) |
(0.9) |
Total shown in the |
||||||
statement of financial position |
(19.1) |
(6.2) |
(12.6) |
(96.0) |
(133.9) |
(134.4) |
Contractual maturities of liabilities |
Less than |
Between |
Between |
Total contractual |
Carrying |
|
at 31 March 2025 (£m) |
6 months |
6–12 months |
1–2 years |
2–5 years |
cash flows |
amount |
Trade and other payables |
(13.0) |
(0.1) |
– |
– |
(13.1) |
(13.1) |
Fees on facility |
0.6 |
– |
– |
– |
0.6 |
0.6 |
Facility |
(6.3) |
(6.3) |
(126.3) |
– |
(138.9) |
(120.0) |
Provisions |
– |
(0.1) |
– |
– |
(0.1) |
(0.1) |
Current lease liabilities |
(0.1) |
(0.2) |
– |
– |
(0.3) |
(0.3) |
Non-current lease liabilities |
– |
– |
(0.8) |
(0.5) |
(1.3) |
(1.3) |
Total shown in the |
||||||
statement of financial position |
(18.8) |
(6.7) |
(127.1) |
(0.5) |
(153.1) |
(134.2) |
31 March 2026 |
31 March 2025 |
|
Classes of financial assets impacted by credit risk, carrying amounts |
£m |
£m |
Trade and other receivables |
4.1 |
1.9 |
Cash and cash equivalents |
51.7 |
89.0 |
Total |
55.8 |
90.9 |
Year ended |
Year ended |
|
31 March 2026 |
31 March 2025 |
|
£m |
£m |
|
Wages and salaries |
2.5 |
2.4 |
Share-based payment |
0.6 |
0.0 |
Defined contribution pension costs |
0.2 |
0.2 |
Social security contributions and similar taxes |
0.5 |
0.3 |
Carried interest paid |
1.8 |
2.8 |
Total |
5.6 |
5.7 |
Year ended |
Year ended |
|
31 March 2026 |
31 March 2025 |
|
Management fees recognised in the statement of comprehensive income resulting from related party transactions |
£m |
£m |
Management fees from unconsolidated structured entities |
12.2 |
12.0 |
Management fees from EIS and VCT funds |
3.3 |
6.1 |
Year ended |
Year ended |
|
31 March 2026 |
31 March 2025 |
|
£m |
£m |
|
Carry payments |
1.8 |
3.5 |
Year ended |
Year ended |
|
31 March 2026 |
31 March 2025 |
|
£m |
£m |
|
Performance fees |
0.1 |
0.4 |
31 March | 31 March | |||||
2026 | 2025 | |||||
Name of undertaking | Registered office | Activity | Holding | Country | £m | £m |
Esprit Investments (1)(B) LP | 20 Garrick Street, | Limited Partnership pursuant to which the | 100% | England | 12.5 | 10.3 |
London, WC2E 9BT | Group and Molten Ventures FoF I LP hold | |||||
Fund of Fund investments | ||||||
Esprit Investments (2)(B) LP | 20 Garrick Street, | Limited Partnership pursuant to which the | 100% | England | 92.4 | 73.3 |
London, WC2E 9BT | Group and Molten Ventures FoF I LP hold | |||||
Fund of Fund investments | ||||||
Molten Ventures (Ireland) | 32 Molesworth Street, | Investment entity | 100% | Ireland | 672.9 | 789.6 |
Limited | Dublin 2, Ireland | |||||
Esprit Capital III, L.P. | 20 Garrick Street, | Limited Partnership pursuant to which the | 100% | England | – | 2.9 |
London, WC2E 9BT | Group makes certain investments | |||||
Esprit Capital IV LP | 20 Garrick Street, | Limited Partnership pursuant to which the | 100% | England | – | 0.8 |
London, WC2E 9BT | Group makes certain investments | |||||
Esprit Investments (1) L.P. | 20 Garrick Street, | Limited Partnership pursuant to which the | 100% | England | 150.1 | 116.6 |
London, WC2E 9BT | Group makes certain investments | |||||
Esprit Investments (2) LP | 20 Garrick Street, | Limited Partnership pursuant to which the | 100% | England | 522.9 | 669.4 |
London, WC2E 9BT | Group makes certain investments | |||||
Molten Ventures Holdings | 20 Garrick Street, | Intermediate Company and Qualifying Asset | 100% | England | 523.1 | 295.1 |
Ltd | London, WC2E 9BT | Holding Company (“QAHC”) | ||||
Molten Ventures | 20 Garrick Street, | Limited Partnership pursuant to which the | 100% | England | 324.3 | 116.0 |
Investments LP | London, WC2E 9BT | Group makes certain investments | ||||
Molten Ventures FoF I LP | 20 Garrick Street, | Limited partnership under the Group’s | 100% | England | 42.9 | 16.0 |
London, WC2E 9BT | management which makes Fund of Fund | |||||
investments | ||||||
Molten Ventures FoF II LP | 20 Garrick Street, | Limited partnership under the Group’s | 100% | England | 0.7 | – |
London, WC2E 9BT | management which makes Fund of Fund | |||||
investments | ||||||
Molten Ventures | 20 Garrick Street, | Limited Partnership under the Group's | 56% | England | 11.3 | 11.2 |
Investments (Ireland) I LP | London, WC2E 9BT | management which makes Irish domiciled | ||||
investments | ||||||
Esprit Investments (2)(B) | 20 Garrick Street, | Limited Partnership pursuant to which the | 100% | England | 207.9 | 202.2 |
(II) LP | London, WC2E 9BT | Group makes certain investments | ||||
Forward Partners 1 L.P. | 20 Garrick Street, | Limited Partnership pursuant to which the | 100% | England | 12.4 | 14.4 |
London, WC2E 9BT | Group makes certain investments | |||||
Forward Partners III L.P. | 20 Garrick Street, | Limited Partnership pursuant to which the | 100% | England | 14.6 | 29.8 |
London, WC2E 9BT | Group makes certain investments | |||||
Forward Partners II L.P. | 20 Garrick Street, | Limited Partnership pursuant to which the | 100% | England | 20.7 | 14.3 |
London, WC2E 9BT | Group makes certain investments |
31 March 2026 |
31 March 2025 |
|
£m |
£m |
|
Undrawn capital commitments |
50.3 |
55.0 |
Total capital commitments |
366.6 |
311.2 |